Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126854281 | 12685428 | 1 | I | 20160817 | 20160825 | 20160825 | EXP | CA-PFIZER INC-2016401729 | PFIZER | 0.00 | F | Y | 0.00000 | 20160825 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126854281 | 12685428 | 1 | SS | ENBREL | ETANERCEPT | 1 | 50 MG, QWK | U | 0 | 50 | MG | /wk | |||||||
| 126854281 | 12685428 | 2 | SS | CODEINE | CODEINE | 1 | UNK | U | 0 | ||||||||||
| 126854281 | 12685428 | 3 | PS | SULFASALAZINE. | SULFASALAZINE | 1 | 2 MG, QD | U | 7073 | 2 | MG | QD | |||||||
| 126854281 | 12685428 | 4 | SS | ABATACEPT | ABATACEPT | 1 | Intravenous (not otherwise specified) | 750 MG, Q4WK | U | 0 | 750 | MG | |||||||
| 126854281 | 12685428 | 5 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | 20 MG, QD | U | 0 | 20 | MG | TABLET | QD | ||||||
| 126854281 | 12685428 | 6 | C | ARTHROTEC | DICLOFENAC SODIUMMISOPROSTOL | 1 | UNK | 0 | TABLET | ||||||||||
| 126854281 | 12685428 | 7 | C | ASPIRIN. | ASPIRIN | 1 | UNK | 0 | |||||||||||
| 126854281 | 12685428 | 8 | C | CARBIDOPA/LEVODOPA | 2 | UNK | 0 | ||||||||||||
| 126854281 | 12685428 | 9 | C | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | UNK | 0 | |||||||||||
| 126854281 | 12685428 | 10 | C | CLARITIN | LORATADINE | 1 | UNK | 0 | |||||||||||
| 126854281 | 12685428 | 11 | C | FERROUS FUMARATE | FERROUS FUMARATE | 1 | UNK | 0 | |||||||||||
| 126854281 | 12685428 | 12 | C | FERROUS GLUCONATE | FERROUS GLUCONATE | 1 | UNK | 0 | |||||||||||
| 126854281 | 12685428 | 13 | C | FOLIC ACID. | FOLIC ACID | 1 | UNK | 0 | |||||||||||
| 126854281 | 12685428 | 14 | C | LOSEC | OMEPRAZOLE | 1 | UNK | 0 | |||||||||||
| 126854281 | 12685428 | 15 | C | METHOTREXATE. | METHOTREXATE | 1 | UNK | 0 | |||||||||||
| 126854281 | 12685428 | 16 | C | PREVACID | LANSOPRAZOLE | 1 | UNK | 0 | |||||||||||
| 126854281 | 12685428 | 17 | C | REACTINE | CETIRIZINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 126854281 | 12685428 | 18 | C | SINEMET | CARBIDOPALEVODOPA | 1 | UNK | 0 | TABLET | ||||||||||
| 126854281 | 12685428 | 19 | C | TOPIRAMATE. | TOPIRAMATE | 1 | UNK | 0 | |||||||||||
| 126854281 | 12685428 | 20 | C | BUDESONIDE W/FORMOTEROL FUMARATE | BUDESONIDEFORMOTEROL FUMARATE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126854281 | 12685428 | 1 | Rheumatoid arthritis |
| 126854281 | 12685428 | 4 | Rheumatoid arthritis |
| 126854281 | 12685428 | 5 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126854281 | 12685428 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126854281 | 12685428 | C-reactive protein abnormal | |
| 126854281 | 12685428 | Dermatitis psoriasiform | |
| 126854281 | 12685428 | Drug ineffective | |
| 126854281 | 12685428 | Hepatic enzyme increased | |
| 126854281 | 12685428 | Pain in extremity | |
| 126854281 | 12685428 | Psoriasis | |
| 126854281 | 12685428 | Red blood cell sedimentation rate abnormal | |
| 126854281 | 12685428 | Rheumatoid arthritis | |
| 126854281 | 12685428 | Skin depigmentation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |